Treatment Options for Female Androgenetic Alopecia

First-Line Treatments

• The American Academy of Dermatology recommends treatment with minoxidil, which must be continued indefinitely to maintain results, as discontinuation leads to reversal of hair growth benefits 1

Advanced Treatment Options

• Platelet-rich plasma (PRP) therapy induces proliferation of dermal papilla cells, increasing vascularization of perifollicular tissue and accelerating telogen-to-anagen transition 1
• The combination of PRP with topical minoxidil shows superior efficacy compared to either treatment alone, with the highest increase in hair density in comparative studies 2
• Complex therapy (PRP with minoxidil) is significantly more effective than minoxidil monotherapy, with recommended protocol of three treatment sessions spaced one month apart 2

Treatment Protocol for PRP/PRF

• For optimal results with combination therapy, apply topical minoxidil 5% (1 mL) twice daily and combine with monthly PRP injections for at least 3 sessions 2

Monitoring Treatment Efficacy

• Evaluate treatment response using multiple methods, including standardized before-and-after photographs, trichoscopy, and patient self-assessment questionnaires 1
• Key indicators of positive response include increased hair density, increased hair shaft diameter, decreased proportion of telogen hairs, and improved patient satisfaction scores 1, 2
• Low-level laser light therapy (LLLT) is another option with demonstrated efficacy in female androgenetic alopecia, with recommended usage of three times per week 1
• Inadequate follow-up to assess treatment response can lead to suboptimal outcomes, highlighting the importance of regular monitoring 1

Treatment of Female Androgenetic Alopecia

Emerging Treatments

• The combination of platelet-rich plasma (PRP) and minoxidil is more effective than minoxidil alone, according to the American Academy of Periodontology 3
• Platelet-rich fibrin (PRF) has theoretical advantages over PRP, with a recommended protocol of 3-5 sessions at 1-month intervals, using 5-7 mL of PRP at a rate of 0.05 to 0.1 mL/cm², with injections at 1 cm intervals and a depth of 2 to 4 mm, and a maintenance phase of 1 session every 6 months 4
• The use of PRP/PRF may be associated with pain, and local anesthesia with pharmaceutical-grade anesthetic cream is strongly recommended 4

Evaluation of Treatment Efficacy

• Standardized before-and-after photographs, trichoscopy to evaluate hair density and diameter, hair pull tests to evaluate hair fragility, and patient self-assessment questionnaires can be used to evaluate treatment efficacy, as recommended by the American Academy of Periodontology 5

Important Considerations

• The efficacy of treatments may decrease with the severity and duration of alopecia, according to the American Academy of Periodontology 4

Platelet-Rich Plasma Protocol for Androgenetic Alopecia

Treatment Protocol

• The manual double-spin method should be used for PRP preparation, with a recommended platelet concentration of 1 to 1.5 million platelets per µL, and PRP activation is NOT required for androgenetic alopecia 6
• A minimum of 3-5 sessions at 1-month intervals should be performed, with a dose of 5-7 mL PRP, using 0.05 to 0.1 mL/cm², and an injection technique of 90-degree angle, 2-4 mm depth, injections 1 cm apart 6
• Maintenance phase should consist of 1 session every 6 months after initial treatment phase 6
• Pharmaceutical-grade topical anesthetic cream should be applied before injection due to significant pain, and patient must shampoo and detangle hair before session, with no hair products applied 6
• Use 30G × 4 mm needles to minimize discomfort 6

Evaluation and Monitoring

• Standardized before-and-after photographs should be used to evaluate treatment response, in addition to other assessment tools such as trichoscopy and patient self-assessment questionnaires 6
• Treatment response should be evaluated after one year of PRP combination therapy 6

Treatment of Female Androgenetic Alopecia with Combination Therapy

Expected Outcomes with Combination Therapy

• 83% of patients achieve a negative hair pull test after treatment with PRP combined with minoxidil, indicating reduced hair fragility 7

Treatment Protocol for Female Androgenetic Alopecia

Advanced Combination Therapy

• The American Academy of Periodontology recommends using nonactivated PRP, as it shows 31% greater improvement in hair density compared to activated PRP, in patients with androgenetic alopecia 8
• The use of PRP injections, with a platelet concentration of 1-1.5 million platelets per µL, produces significant improvements in hair density and diameter, with a 25% improvement in hair density at 2 months predicting sustained response at 6 months, in patients with androgenetic alopecia 8
• The application of pharmaceutical-grade topical anesthetic cream before PRP injection is recommended due to significant pain, in patients undergoing PRP therapy for androgenetic alopecia 8
• Maximum response with PRP is typically achieved by 6 months, with regular monitoring and evaluation of treatment response, in patients with androgenetic alopecia 8
• Insufficient treatment duration can lead to suboptimal outcomes, with some patients requiring extended therapy beyond initial 6 months, in patients with androgenetic alopecia 8

Optimal Duration for Minoxidil Monotherapy Reevaluation in Androgenetic Alopecia

Evidence-Based Monitoring Parameters

• The American Academy of Dermatology recommends monitoring terminal versus vellus hair ratio as an indicator of treatment efficacy, with significant changes observed in clinical trials 9
• Patient-reported outcomes, including subjective assessment of hair thickness and ease of styling, are also crucial in evaluating treatment response, as noted by the National Institute of Health 9

Minoxidil and PRP Therapy for Androgenetic Alopecia

Introduction to Treatment Protocols

• The American Academy of Dermatology recommends applying pharmaceutical-grade topical anesthetic cream before PRP injections to minimize discomfort in patients undergoing PRP therapy for androgenetic alopecia, with significant pain associated with the procedure 10

Combination Therapy Outcomes

• Combination therapy of minoxidil 5% topical solution and PRP injections achieves a 57% median increase in terminal hair density versus 48% with minoxidil alone at 32 weeks, with 83% of patients achieving a negative hair pull test, indicating reduced hair fragility 10

Platelet-Rich Plasma Therapy for Female Androgenetic Alopecia

Second-Line Treatment: Adding PRP Therapy

• The American Academy of Periodontology and Indian Association of Dermatologists provide specific technical parameters for PRP therapy, including a manual double-spin method, target platelet concentration of 1 to 1.5 million platelets per µL, and nonactivated PRP, which shows 31% greater improvement in hair density compared to activated PRP, for patients with suboptimal response to minoxidil monotherapy 11
• The American Academy of Periodontology and Indian Association of Dermatologists recommend a minimum of 3-5 PRP sessions at 1-month intervals, with a dose of 5-7 mL PRP, using 0.05 to 0.1 mL/cm², and injection technique at a 90-degree angle, 2-4 mm depth, injections 1 cm apart, for patients with female androgenetic alopecia 11
• The American Academy of Periodontology and Indian Association of Dermatologists suggest applying pharmaceutical-grade topical anesthetic cream before PRP injection, due to significant pain associated with the procedure, for patients undergoing PRP therapy 11
• The American Academy of Periodontology and Indian Association of Dermatologists recommend a maintenance phase of 1 PRP session every 6 months after initial treatment, to sustain hair growth benefits, for patients with female androgenetic alopecia 11

Minoxidil Treatment Protocol for Androgenetic Alopecia

Critical Pitfalls to Avoid

• Low platelet concentration, inadequate injection volume, or insufficient treatment frequency leads to PRP treatment failure, as stated by the Periodontology 2000 guideline society 12
• Individual genetic factors significantly influence response to all treatments, according to the Periodontology 2000 guideline society 12

Alternative and Emerging Options

• Platelet-Rich Fibrin (PRF) shows promise as a potentially superior alternative to PRP with theoretical advantages including lower cost, easier preparation, and sustained growth factor release, as reported in the Periodontology 2000 journal 12

Management of Androgenetic Alopecia with Combination Therapy

Introduction to Combination Therapy

• The American Academy of Periodontology and Indian Association of Dermatologists recommend combination therapy for optimal results in patients with androgenetic alopecia, with a 57% median increase in terminal hair density versus 48% with minoxidil alone 13

Patient Selection and Treatment Approach

• This approach is specifically for androgenetic alopecia (pattern hair loss) only, and not appropriate for patchy hair loss (alopecia areata), which requires different treatment 13, 14, 15

Alternative Treatment Options

• Low-level laser therapy (LLLT) with 655-nm laser devices can be used as adjunctive therapy, three times per week 13

Emerging Evidence for Platelet‑Rich Fibrin (PRF) in Androgenetic Alopecia

Clinical Data Supporting PRF

• In patients with androgenetic alopecia, preliminary studies of platelet‑rich fibrin (PRF) demonstrated safety and efficacy that were comparable to platelet‑rich plasma (PRP) — suggesting PRF as a viable emerging alternative to PRP for hair‑regrowth therapy【16】.

• The same preliminary investigations reported theoretical advantages of PRF over PRP, including lower cost, simpler preparation, and a more sustained release of growth factors, which may translate into similar clinical outcomes with added practical benefits【17】.

Low‑Level Laser Therapy (LLLT) Guidelines for Androgenetic Alopecia

Treatment Frequency and Duration

• For patients with androgenetic alopecia, applying a 655 nm low‑level laser device three times per week provides optimal hair regrowth. 18
• Continuous, indefinite use of LLLT is required to maintain the achieved regrowth, mirroring the need for ongoing minoxidil therapy. 18

Discontinuation Risks

• Abrupt cessation of LLLT results in loss of hair‑regrowth gains within months, comparable to the reversal seen after stopping minoxidil. 18

Monitoring Treatment Response

• Efficacy should be documented with standardized before‑and‑after photographs, enabling objective visual comparison over time. 18

Device Selection and Regulatory Status

• Use FDA‑cleared 655 nm laser devices that are specifically marketed for hair regrowth, and apply them consistently three times weekly. 18

Integrated Recommendations for Androgenetic Alopecia Management

Adjunctive Systemic Therapy

• Continuation of background oral finasteride (when tolerated) together with a multivitamin regimen is advised as part of comprehensive hair‑loss care, according to the guidelines reported in Periodontology 2000【19】.

Evidence‑Based Support for Non‑Pharmacologic Mesotherapy

• Platelet‑rich plasma (PRP), platelet‑rich fibrin (PRF) and growth‑factor concentrate (GFC) injections are endorsed by multiple clinical practice guidelines—including the American Academy of Dermatology, the American Academy of Periodontology, and the Indian Association of Dermatologists—as effective adjunctive therapies for androgenetic alopecia when combined with topical minoxidil【19】.